Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Parkinson's Disease

Free Subscription 21.08.2018 1 Brain Res 1 Exp Neurol 1 J Neural Transm (Vienna) 1 Mov Disord 3 Neurol Clin Pract 3 Neurology 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Brain Res

1. HONJO Y, Ayaki T, Horibe T, Ito H, et al
   FKBP12-immunopositive inclusions in patients with alpha-synucleinopathies.
   Brain Res. 2018;1680:39-45.
   PubMed     Text format     Abstract available
   
   

   
   Exp Neurol

2. OLIVEIRA LM, Falquetto B, Moreira TS, Takakura AC, et al
   Orexinergic neurons are involved in the chemosensory control of breathing during the dark phase in a Parkinson's disease model.
   Exp Neurol. 2018;309:107-118.
   PubMed     Text format     Abstract available
   
   

   
   J Neural Transm (Vienna)

3. BORTOLANZA M, Nascimento GC, Socias SB, Ploper D, et al
   Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease.
   J Neural Transm (Vienna). 2018 Aug 14. pii: 10.1007/s00702-018-1913.
   PubMed     Text format     Abstract available
   
   

   
   Mov Disord

4. PHILLIPS MCL, Murtagh DKJ, Gilbertson LJ, Asztely FJS, et al
   Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial.
   Mov Disord. 2018 Aug 11. doi: 10.1002/mds.27390.
   PubMed     Text format     Abstract available
   
   

   
   Neurol Clin Pract

5. BERMAN BD, Hawkins T
   Author response: Pimavanserin: A novel therapeutic option for Parkinson disease psychosis.
   Neurol Clin Pract. 2018;8:175-176.
   PubMed     Text format    
   
   
6. KEYS LAWLER AC, Torres-Yaghi Y, Amjad F, Moussa C, et al
   Reader response: Pimavanserin: A novel therapeutic option for Parkinson disease psychosis.
   Neurol Clin Pract. 2018;8:175.
   PubMed     Text format    
   
   
7. PARASHOS SA, Bloem BR, Browner NM, Giladi N, et al
   What predicts falls in Parkinson disease?: Observations from the Parkinson's Foundation registry.
   Neurol Clin Pract. 2018;8:214-222.
   PubMed     Text format     Abstract available
   
   

   
   Neurology

8. ADAMS JL, La Morgia C
   The search for Parkinson disease biomarkers: Retinal thinning as a correlate of dopamine loss.
   Neurology. 2018 Aug 15. pii: WNL.0000000000006148.
   PubMed     Text format    
   
   
9. AHN J, Lee JY, Kim TW, Yoon EJ, et al
   Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease.
   Neurology. 2018 Aug 15. pii: WNL.0000000000006157.
   PubMed     Text format     Abstract available
   
   
10. KLEPITSKAYA O, Liu Y, Sharma S, Sillau SH, et al
    Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006162.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

11. CHAHINE LM, Urbe L, Caspell-Garcia C, Aarsland D, et al
    Cognition among individuals along a spectrum of increased risk for Parkinson's disease.
    PLoS One. 2018;13:e0201964.
    PubMed     Text format     Abstract available
    
    
12. KAWASAKI T, Mikami K, Kamo T, Aoki R, et al
    Motor planning error in Parkinson's disease and its clinical correlates.
    PLoS One. 2018;13:e0202228.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: